KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $980,000 | +199.7% | 210,666 | +277.0% | 0.01% | +233.3% |
| Q4 2016 | $327,000 | +10.1% | 55,878 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $297,000 | -21.8% | 55,878 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $380,000 | +45.6% | 55,878 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $261,000 | -23.9% | 55,878 | -17.8% | 0.00% | -33.3% |
| Q4 2015 | $343,000 | +41.7% | 67,948 | -1.0% | 0.00% | +50.0% |
| Q3 2015 | $242,000 | -85.8% | 68,662 | -59.8% | 0.00% | -84.6% |
| Q2 2015 | $1,703,000 | +3.0% | 170,690 | +31.3% | 0.01% | +8.3% |
| Q1 2015 | $1,654,000 | -17.7% | 129,956 | -8.5% | 0.01% | -20.0% |
| Q4 2014 | $2,010,000 | +3.4% | 142,047 | +0.5% | 0.02% | 0.0% |
| Q3 2014 | $1,944,000 | -14.7% | 141,360 | -4.6% | 0.02% | -6.2% |
| Q2 2014 | $2,279,000 | – | 148,171 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |